Curtis joined Metrum in 2014 after receiving his Pharm.D. from the University at Buffalo and completing a clinical PK/PD Fellowship through UNC Chapel Hill/Quintiles. His clinical experience includes infectious disease (bacterial), oncology, and chronic liver disease (HCV and NASH). Curtis’s research interests include Bayesian methodology and the application of M&S to help inform drug development decisions.
Ferslew BC, Johnston CK, Tsakalozou EF, Barritt AS and Brouwer KLR. Altered Morphine-Glucuronide Disposition in Patients with Non-Alcoholic Steatohepatitis. [Accepted] Clinical Pharmacology and Therapeutics, December 2014.
Ferslew BC, Johnston CK, Tsakalozou EF, Su MI, Xie GU, Jia WE, Brouwer KLR and Barritt AS. Altered Fasting and Postprandial Serum Bile acids in Patients with Non-Alcoholic Steatohepatitis (NASH). Presented at the American Association For The Study Of Liver Diseases Annual Meeting, Boston, MA, November 2014.
C.K. Johnston, B.C. Ferslew, A.S. Barritt, K.L. Brouwer. Mathematical Modeling of Systemic and Hepatic Disposition of Morphine and Morphine Glucuronides in Nonalcoholic Steatohepatitis to Inform Study Design. Presented at the American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, TX, November 2013.
Johnston CK, Tsuji BT. Attenuation of Vancomycin Pharmacodynamics (PD) Due to Dense Inoculum Methicillin-Resistant Staphylococcus aureus (MRSA). Presented at the American College of Clinical Pharmacy Annual Meeting, Pittsburgh, PA, October 2011.